RGS19

RGS19 (also known as GAIP, Gα-interacting protein) is a member of the regulator of G-protein signaling (RGS) family that functions as a GTPase-activating protein (GAP) for heterotrimeric G-protein α subunits, thereby accelerating GTP hydrolysis and terminating GPCR-mediated signaling pathways^[1][2]. Mechanistically, RGS19 preferentially interacts with Gα_i family proteins, particularly Gα_i3, and suppresses downstream Gα_i- and Gα_q-linked signal transduction, establishing a key regulatory checkpoint in cellular responses to extracellular stimuli^[3][4]. Consistent with its role in signal attenuation, RGS19 has been localized to membrane-associated compartments and clathrin-coated vesicles, supporting spatial regulation of G-protein signaling and receptor trafficking processes^[5]. In disease-relevant settings, phosphorylation-dependent activation of RGS19 has been reported to enhance its GAP activity and regulate autophagy-related signaling in human colon cancer cells, indicating a functional connection between GPCR regulation and tumor-associated cellular adaptation pathways^[6]. Compared with related RGS isoforms such as RGS4, which also exhibits GAP activity toward Gα_i proteins, RGS19 is distinguished by its strong association with Gα_i3 and its characteristic membrane-targeting mechanisms mediated by lipid modification and protein-protein interactions^[2][3][7]. For experimental applications, RGS19 is widely used as a model RGS protein for investigating GPCR desensitization, G-protein deactivation kinetics, and molecular mechanisms governing selective RGS-Gα interactions^[1][2][7].